Surveillance procedures for patients for cervical carcinoma: A review of the literature

International Journal of Gynecological Cancer

Volumn 19, Issue 3, 2009, Pages 306-313

  Zanagnolo, Vanna ^a   Minig, Lucas Alfonso ^a   Gadducci, Angelo ^b   Maggino, Tiziano ^c   Sartori, E ^d   Zola, Paolo ^e   Landoni, Fabio ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

Cervical cancer recurrence; Computed tomography; FDG positron emission tomography computed tomography; Follow up; Magnetic resonance imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RECURRENCE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPANICOLAOU TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; UTERINE CERVIX CARCINOMA;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; POPULATION SURVEILLANCE; UTERINE CERVICAL NEOPLASMS;

EID: 68149181737     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a130f3     Document Type: Review

References (19)

1. Bodurka-Bevers D., Morris M., Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000;78:187-193.
2. Kosary CL, Schiffman MH, Trimble EL. Cervix uteri. In: Miller BA, Ries LAG, Hankey BF, et al. eds. SEER Cancer Statistic Review. Bethesda, MD: United States Department of Health and Human Services; 1973-1990, 1993.
3. Greenlee RT, Murray T., Bolden S., et al. Cancer Statistics, 2000. Cancer Stat. 2000;50:7-33.
4. Olaitan A., Murdoch J., Anderson R., et al. A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. Int J Gynecol Cancer. 2001;11:349-353.
5. Lim KC, Howells RE, Evans AS. The role of clinical follow up in early stage cervical cancer in South Wales. BJOG. 2004;111:1444-1448.
6. DiSaia PJ, Creasman WT. Clinical gynecologic oncology. 6th ed. St Louis, Mo: Mosby; 2002:53-95.
7. Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67: 2776-2785.
8. Burghardt E. Surgical Gynecologic Oncology. New York: Thieme Medical Publishers, Inc.; 1993:185-322.
9. Duyn A., Van Eijkeren M., Kenter G., et al. Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand. 2002;81:351-355.
10. Benedet JL, Odicino F., Maisonneuve P., et al. Carcinoma of the cervix uteri. 25th volume of the FIGO annual report on the results of treatment of gynecological cancer. Int J Gynaecol Obstet. 2003;83:41-78.
11. Perez CA, Grigsby PW, Camel HM, et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1995;31:703-716.
12. Gerdin E., Cnattingius S., Johnson P., et al. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol. 1994;53:314-319.
13. Larson DM, Copeland LJ, Malone JM Jr, et al. Diagnosis of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1988; 71:6-9.
14. Ansink A., de Barros Lopes A., Naik R., et al. Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance. Br J Obstet Gynaecol. 1996;103:1156-1158.
15. Kew FM, Cruickshank DJ. Routine follow-up after treatment for a gynecological cancer: a survey of practice. Int J Gynecol Cancer. 2006;16:380-384.
16. Barnhill D., O'Connor D., Farley J., et al. Clinical surveillance of gynecologic cancer patients. Gynecol Oncol. 1992;46:275-280.
17. Zola P., Fuso L., Mazzola S., et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol. 2007;107: S150-154.
18. Soisson AP, Geszler G., Soper JT, et al. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1990;76:106-109.
19. Chien CR, Ting LL, Hsieh CY, et al. Post-radiation Pap smear for Chinese patients with cervical cancer: a ten-year follow-up. Eur J Gynaecol Oncol. 2005;26:619-622.